🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
STR
$STRO
🔒 US EquitiesSutro Biopharma Inc
AVG HISTORICAL GAP
+0.29%
MAX GAP RECORD
-20.00%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $STRO
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$STRO
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (UNDETERMINED) |
+0.00%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+0.56%
|
| Mar 23, 2026 Earnings Release 2026-03-23 (AFTER CLOSE) |
+8.81%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-4.26%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
+0.00%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+1.01%
|
| Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE) |
-20.00%
|
| Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE) |
-1.77%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.6%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗